The symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers is known as Carrier Female Symptomatic Muscular Dystrophy (CFSMD). This form of muscular dystrophy is caused by a mutation in the dystrophin gene, which is located on the X chromosome. Symptoms of CFSMD can include muscle weakness, muscle wasting, and difficulty walking. In some cases, female carriers may also experience cardiac and respiratory problems.

The symptoms of Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers vary depending on the type of mutation. Generally, female carriers may experience mild muscle weakness, muscle wasting, joint contractures, and difficulty walking. They may also experience fatigue, difficulty climbing stairs, and difficulty rising from a seated position. In some cases, female carriers may also experience cardiac and respiratory problems.

The cause of Duchenne and Becker muscular dystrophy in female carriers is a mutation in the X-linked gene that codes for dystrophin, a protein that helps keep muscle cells intact. This mutation is inherited from the mother, who is a carrier of the mutated gene. Female carriers may experience milder symptoms than males, but can still experience muscle weakness, fatigue, and difficulty walking.

The treatments for symptomatic forms of Duchenne and Becker muscular dystrophy in female carriers are largely supportive. This includes physical therapy, occupational therapy, and speech therapy to help maintain muscle strength and function. Other treatments may include medications to help manage pain, muscle spasms, and other symptoms. Surgery may be recommended to correct any deformities or joint contractures. In some cases, orthopedic braces may be used to help support weakened muscles.

1. Family history of Duchenne or Becker muscular dystrophy.
2. Having a male relative with Duchenne or Becker muscular dystrophy.
3. Having a mutation in the dystrophin gene.
4. Having a mutation in the dystrophin-associated protein complex.
5. Having a mutation in the X-linked gene that codes for dystrophin.
6. Having a mutation in the dystrophin-related protein gene.
7. Having a mutation in the dystrophin-associated glycoprotein gene.
8. Having a mutation in the dystrophin-associated protein complex gene.
9. Having a mutation in the dystrophin-associated protein complex gene that affects the production of dystrophin.
10. Having a mutation in the dy

At this time, there is no cure for Duchenne or Becker muscular dystrophy in female carriers. However, there are medications available to help manage the symptoms of the condition. These medications can help to reduce muscle spasms, improve muscle strength, and slow the progression of the disease. Additionally, physical and occupational therapy can help to improve mobility and quality of life.